Resmed (RSMDF) Receivables - Net (2010 - 2026)

Resmed (RSMDF) has reported Receivables - Net for 17 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables - Net rose 10.3% year-over-year to $1.0 billion; the trailing twelve-month figure through Jun 2026 stood at $1.0 billion (up 10.3% YoY), and the FY2026 full-year result was $1.0 billion, up 10.3% from the prior year.
• Receivables - Net climbed to $1.0 billion in Q2 2026 per RSMDF's latest filing, from $998.8 million in the prior quarter.
• Across five years, Receivables - Net topped out at $1.0 billion in Q2 2026 and bottomed at $508.6 million in Q1 2022.
• Historically, Receivables - Net has averaged $791.9 million across 5 years, with a median of $795.2 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Receivables - Net decreased 6.24% in 2022, then jumped 34.94% in 2023.
• Over 5 years, Receivables - Net stood at $672.3 million in 2022, then advanced by 8.55% to $729.7 million in 2023, then rose by 17.84% to $859.9 million in 2024, then advanced by 14.62% to $985.6 million in 2025, then gained by 5.13% to $1.0 billion in 2026.
• According to Business Quant data, Receivables - Net over the past three periods registered $1.0 billion, $998.8 million, and $985.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.